An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients

被引：4
|
作者：
Chakravarti, A.
Berkey, B.
Robins, H. I.
Guha, A.
Curran, W.
Brachman, D.
Shultz, C.
Mehta, M.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Thomas Jefferson Med Coll, Philadelphia, PA USA
[6] Fdn Canc Res, Phoenix, AZ USA
[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Wei, Kuo-Chen
    Hsu, Peng-Wei
    Tsai, Hong-Chieh
    Lin, Ya-Jui
    Chen, Ko-Ting
    Toh, Cheng-Hong
    Huang, Hui-Lin
    Jung, Shih-Ming
    Tseng, Chen-Kan
    Ke, Yu-Xiong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Kuo-Chen Wei
    Peng-Wei Hsu
    Hong-Chieh Tsai
    Ya-Jui Lin
    Ko-Ting Chen
    Cheng-Hong Toh
    Hui-Lin Huang
    Shih-Ming Jung
    Chen-Kan Tseng
    Yu-Xiong Ke
    Scientific Reports, 11
  • [23] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Prados, Michael D.
    Chang, Susan M.
    Butowski, Nicholas
    DeBoer, Rebecca
    Parvataneni, Rupa
    Carliner, Hannah
    Kabuubi, Paul
    Ayers-Ringler, Jennifer
    Rabbitt, Jane
    Page, Margaretta
    Fedoroff, Anne
    Sneed, Penny K.
    Berger, Mitchel S.
    McDermott, Michael W.
    Parsa, Andrew T.
    Vandenberg, Scott
    James, C. David
    Lamborn, Kathleen R.
    Stokoe, David
    Haas-Kogan, Daphne A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 579 - 584
  • [24] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
  • [25] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Rauf, Yasmeen
    Peereboom, David
    Fallah, Jaleh
    Schilero, Cathy
    Lackner, Pamela
    Stevens, Glen
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [26] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [27] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [28] Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
    Blakeley, Jaishri O.
    Grossman, Stuart A.
    Chi, Andrew S.
    Mikkelsen, Tom
    Rosenfeld, Myrna R.
    Ahluwalia, Manmeet S.
    Nabors, L. Burt
    Eichler, April
    Ribas, Ignacio Garcia
    Desideri, Serena
    Ye, Xiaobu
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 73 - 79
  • [29] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [30] Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis
    Navarria, Pierina
    Pessina, Federico
    Cozzi, Luca
    Tomatis, Stefano
    Reggiori, Giacomo
    Simonelli, Matteo
    Santoro, Armando
    Clerici, Elena
    Franzese, Ciro
    Carta, Giulio
    Nibali, Marco Conti
    Bello, Lorenzo
    Scorsetti, Marta
    TUMORI JOURNAL, 2019, 105 (01): : 47 - 54
12345